The services provided
by Blackrock Clinic Pathology Department are:
• Clinical Biochemistry/Endocrinology/Point of Care
Testing
• Haematology
• Blood Transfusion / Haemovigilance
• Microbiology
• Cellular Pathology
The examinations performed in
each discipline, including sample requirements and expected turnaround times (eTAT),
are listed in the appendices. Test methodologies are approved by departmental
consultants and are available on request.
INAB accredited activities are defined in the scope of accreditation as
detailed on the INAB website (www.inab.ie),
registration number 212MT. The
Biochemistry department has been awarded flexible scope by INAB, for further
details refer to the laboratories “master list of flexible scope changes” (MF-GEN-0166),
available directly from the laboratory.
For specialist examinations,
Blackrock Clinic sources outside laboratories based on their ability to provide
a quality service and include those that are a reference laboratory for specialist
examinations, a university teaching hospital laboratory and/or an accredited laboratory,
e.g. INAB or UKAS ISO 15189 accredited.
Haemovigilance is defined as a “set of surveillance
procedures from the collection of blood and its components to the follow–up of recipients,
to collect and assess information on unexpected or undesirable effects resulting
from the therapeutic use of labile blood products, and to prevent their occurrence”
(National Haemovigilance Office, 2004.)
Reporting of adverse reactions and events has been viewed
as part of professional responsibility and is based on a confidential anonymous
reporting system. The advent of EU directive
(2002/98/EC) in February 2005 specifies:
• That all serious adverse reactions and serious adverse
events which are attributed
to the quality and safety of blood components transfused
will be captured and
reported.
• That all blood products are traceable from donor to
recipient. This information
must be available for thirty years. This will comprise
of weekday surveillance
procedures and involve the audit of the haemovigilance
process.
If you suspect a transfusion reaction, please contact
either the blood transfusion laboratory on Ph: 01 2064224 or the Haemovigilance
Officer / Deputy Haemovigilance Officer on DECT phone 8041. Out of hours, contact the on call scientist.
Point of Care Testing is
defined as any testing carried out close to the patient, away from the central
laboratory, carried out by non-pathology staff. A limited range of tests and
procedures are performed by non-pathology staff. The Point of Care Testing in the Blackrock
Clinic involves the following equipment:
- Siemens RP500 Blood Gas Analysers
- Siemens Clinitek Status Analysers for
Urinalysis and uHCG testing
- Haemochron Signature + for ACT testing
- Abbott Freestyle Pro Glucose and Ketone meters
The location of each point
of care device is documented in LF-POC-0030 Point of Care Device Locations.
A designated Point of Care
Coordinator is responsible for the controlled operation of Point of Care
Testing procedures and requirements and can be contacted through the
Biochemistry Department on extension 4397.